Searched for
OPHTHALMIC PRODUCT
Lupin arm to commercialise YUVEZZI eye drop across key European marketsLupin's VISUfarma BV has secured exclusive rights for YUVEZZI in key European markets. This ophthalmic product treats loss of clear close-u...- Doctors' safety alert led to Sun Pharma eye drop recallSun Pharma recalled eleven eyecare products after an eye specialists' body issued a safety alert. This alert warned about bacterial contami...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- Jackson Labs' Baddi drug manufacturing licence restored after suspensionThe unit's licence was cancelled in June after several women in Kota, Rajasthan, died allegedly due to spurious oxytocin injections supplie...
- BDR Pharmaceuticals eyes controlling stake in Acme FormulationPAG acquired a controlling stake in Acme Formulation for $145 million (?1,054 crore) through its PAG Asia III buyout fund in 2021. Founder ...
- Alcon to step up India investments; focus on innovation, training, says Senior Vice Prez Rajkumar NarayananAlcon is significantly increasing its investments in India's eye care market. The company sees India as a crucial emerging growth market fo...
- Screens are straining young eyes, and Alcon sees India's opportunityAlcon is increasing investments in India, recognizing its significant emerging market potential. The company focuses on innovation and surg...
- Glenmark launches generic ophthalmic solution in US marketGlenmark Pharmaceuticals' subsidiary has introduced Latanoprost ophthalmic solution, a generic medication for glaucoma, in the US market. T...
- Glenmark launches generic glaucoma treatment ophthalmic solutionGlenmark Pharmaceuticals Inc., USA launched a generic version of Travatan Z, a glaucoma treatment, called Travoprost ophthalmic solution (0...
- Alembic Pharma gets USFDA nod for generic Bromfenac ophthalmic solutionAlembic Pharmaceuticals Ltd has obtained final approval from the US FDA for its generic Bromfenac ophthalmic solution, used to treat postop...
- Lupin gets USFDA nod for Bromfenac Ophthalmic SolutionPharma major Lupin on Wednesday said it has received approval from the US health regulator to market its generic Bromfenac Ophthalmic Solut...
- Teva launches Indoco Remedies-developed generic drug in USThe product, which is a generic version of Azopt ophthalmic suspension, is developed and manufactured by the Mumbai-based drug firm at its ...
- Alembic Pharmaceuticals gets USFDA nod for ophthalmic solutionThe company has received approval from the USFDA for its abbreviated new drug application (ANDA) Olopatadine Hydrochloride ophthalmic solut...
- Local pharma formulators to benefit from new USFDA generic guidance: ReportThis will help domestic pharma formulators with pending ANDA approvals to reduce review cycles and expedite approvals, says a weekend repor...
- Sun Pharma receives USFDA nod ophthalmic solution used to treat dry eye diseaseNew Delhi, Aug 16 () Sun Pharma has received approval from the US health regulator for CEQUA (cyclosporine ophthalmic solution), used to in...
- Alembic Pharma gets tentative USFDA nod for ophthalmic solutionAlembic said it is currently in litigation with Allergan in District Court of New Jersey and the launch of this product will depend on the ...
- Lupin completes acquisition of Mexico's Laboratories GrinMexico is one of the fastest growing pharmaceutical markets in the world valued at over $ 13.5 billion and growing at 9-10% annually.
- Lupin buys Mexico's Laboratorios Grin; forays into LATAM mkt"The acquisition marks Lupin's foray into the high growth Mexican and the larger Latin American (LATAM) pharmaceuticals market," Lupin Ltd ...
- Lupin launches generic ophthalmic solution in US marketLupin launched generic version of Allergan Inc's Zymaxid Ophthalmic Solution in US market with 180 days of marketing exclusivity.
- Indoco in JV to sell ophthalmic products in USIndoco Remedies has formalised a joint venture agreement with New Jersey-based Amneal Pharmaceuticals to market 10 ophthalmic products in t...
Load More
